A Randomized controlled clinical trial to evaluate efficacy between Krushna Churna and Parijatak Gugulu in the management of Gridhrasi.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 68
- 试验地点
- 1
- 主要终点
- To compare efficacy of krushna churna at vynodan kal with
研究概览
简要总结
Gridhrasi is one of the Vataj Nanatmaj vikar.
The location of vayu being kati pradesh , the main concern is the function of locomotion. Being epitome of all the bodily functions , it has the privilege of generating the highest number of diseases described as vataj nanatmaja vikara. Gridhrasi is one of the nanatamaj vikara of vata dosha affecting it’s main sthan that is kati pradesh according to charak samhita.
The character of gridhrasi resembles with sciatica I.e radiating pain along the course and distribution of sciatica nerve that is in buttock to outer border of foot.
The effectiveness of krushna churna with gomutra and erand tail in gridhrasi is mentioned in bhaisjaya ratnavali 26/40.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Open Label
入排标准
- 年龄范围
- 25.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients showing classical symptoms and sign of Gridhrasi that is Padashoola (pain) ,Katishoola (pain),Stambha (stiffness) ,Toda (pricking sensation) ,Spandan (twitching) , Dehasya –Api-Pravakrata (Gait),Aruchi (Anorexia),Tandra (Drowsiness),Gaurav (Heaviness) as described in ayurvedic samhitas in Charak Chikitsasthan 28/57,
- •Radiating pain along the course and distribution of sciatic nerve that is in buttock to outer border of foot.
- •SLR Test of patient – positive upto 60 degree.
- •Patients between the age of 25-65 years.
- •Patients from all socio-economic status.
排除标准
- •Pregnant and lactating mothers.
- •Infective disorders – T.B. spine, osteomyelitis.
- •Patients with paraplegia of lower limb.
- •Fracture of spinal bones or in lower extremity bones
- •Patients having congenital anamolies with lumbosacral spine such as kyphosis, scolisis.
- •Patients having any major chronic/acute; systemic/surgical pathology like malignancies.
- •Patients with deep wounds penetrating till sciatic nerve.
- •Patients with dislocation of hip joint, amputation above knee joint.
- •10.Patients having allergy to any content of drugs.
- •High risk (above 65 years age, known cases of HTN, DM,COPD) comorbid patients suspected for covid
- •Suspected covid 19 patient having symptoms as per ICMR guidelines.
结局指标
主要结局
To compare efficacy of krushna churna at vynodan kal with
时间窗: One month with follow up on 7th 14th 21st and 28th day
gomutra10ml & eranda tail 5 ml For 1month & parijatak gugulu 500 mg tab
时间窗: One month with follow up on 7th 14th 21st and 28th day
at vyonodan kal with koshna jal for 1 month in the management of
时间窗: One month with follow up on 7th 14th 21st and 28th day
Gridhrasi
时间窗: One month with follow up on 7th 14th 21st and 28th day
次要结局
- 1. To compare and study the efficacy of krushna churna.(2. To compare and study the efficacy of Parijatak Gugulu.)